Obermatt

AddLife

STO:ALIF B · SE0014401378
Life Sciences Tools & ServicesMedium

360

83
EV / EBIT35
Price / Owner Earnings42
Owner Earnings Yield93
Dividend Yield45
Price/Sales48
EV / Gross Profit78
Price/Book31
Return on Capital66
Cash Return on Capital87
Return on Equity78
EBIT Margin56
Gross Profitability78
Cash Conversion51
Accruals40
Owner Earnings Margin72
Sales growth32
Profit Growth51
Long-Term EPS Growth97
Owner Earnings Growth84
Reinvestment28
Price momentum39
Debt load41
Refinancing64
Debt Payback35
Liquidity44
Analyst ratings100
Opinion Changes50
Price Target Upside63
Market mood32
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

AddLife generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountrySweden
IndustryLife Sciences Tools & Services
SizeMedium
TypePublic Company
ExchangeOM
Founded2014
Employees38
Websiteadd.life
ISINSE0014401378
Last UpdateApr 2, 2026
Themes
Health DiagnosticsImmunologyOphthalmologyBiomedical EngineeringGeneticsOrthopaedicsBiotechnologyLife ScienceService Industry

Description

Analysis

Middle-of-the-road

AddLife AB (publ) is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 20.6× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 7% yearly growth; analysts expect 33%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 18/20 on our value-creation score: strong value creator.

What to watch: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
37
2023202420252026

All-time high

96

Jan 2023

All-time low

8

Jan 2024

Average rank

47

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
48
69
87
61
Price/Earnings
45
14
26
19
Price/Book
31
34
67
34
Dividend Yield
45
44
51
51
Value (overall)
35
41
72
64

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare AddLife with its peers
Getinge
STO:GETI B
63
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Addtech
STO:ADDT B
65
CountrySweden
IndustryTrading Companies & Distributors
SizeLarge
Full Stock Analysis →
ChemoMetec
CPH:CHEMM
83
CountryDenmark
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Sartorius
GER:SRT
11
CountryGermany
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Eurofins Scientific
PAR:ERF
27
CountryLuxembourg
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Tecan Group
SWX:TECN
25
CountrySwitzerland
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →